Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 949,000 | 826,000 | 1M | 616,000 | 1M | 2M |
| Cost of revenue | 728,000 | 679,000 | 996,000 | 422,000 | 1M | 1M |
| Gross profit | 221,000 | 147,000 | 147,000 | 194,000 | 188,000 | 126,000 |
| Research and development | 76,000 | 82,000 | 74,000 | 50,000 | 137,000 | 140,000 |
| Selling, general and administrative | 286,000 | 240,000 | 297,000 | 412,000 | 449,000 | 543,000 |
| Operating expenses | 362,000 | 322,000 | 371,000 | 462,000 | 586,000 | 683,000 |
| Operating income | −141,000 | −175,000 | −224,000 | −268,000 | −398,000 | −557,000 |
| Net income | −140,000 | −172,000 | −231,000 | −268,000 | −316,000 | −554,000 |
| Earnings per share | −0.02 | −0.03 | −0.04 | −0.05 | −0.06 | −0.12 |
| Earnings per share, diluted | −0.02 | −0.03 | −0.04 | −0.05 | −0.06 | −0.12 |
| Weighted average shares | 6M | 6M | 5M | 5M | 5M | 5M |
| Weighted average shares, diluted | 6M | 6M | 5M | 5M | 5M | 5M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1M | 1M | 897,000 | 499,000 | 488,000 | 565,000 | 819,000 | 1M |
| Receivables | 487,000 | 526,000 | 665,000 |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 69,000 | −55,000 | −215,000 | −272,000 | −267,000 | −718,000 |
| Depreciation and amortisation | 8,000 | 9,000 | 10,000 | 9,000 | 9,000 | 11,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 960,000 |
| 588,000 |
| 804,000 |
| — |
| — |
| Inventory | 4M | 3M | 3M | 3M | 3M | 3M | 4M | 4M |
| Current assets | 6M | 5M | 5M | 4M | 5M | 5M | 6M | 6M |
| Total assets | 6M | 5M | 5M | 5M | 5M | 6M | 6M | 7M |
| Current liabilities | 2M | 922,000 | 2M | 2M | 2M | 2M | 3M | 3M |
| Total liabilities | 2M | 1M | 2M | 2M | 3M | 3M | 3M | 4M |
| Equity | 4M | 4M | 3M | 3M | 3M | 3M | 3M | 4M |
| Shares outstanding | 6M | 6M | 6M | 5M | 5M | 5M | 5M | 5M |
| Shares issued | 6M | 6M | 6M | 5M | 5M | 5M | 5M | 5M |
| Share-based compensation | 0 | 0 | 0 | −4,000 | 1,000 | 0 |
| Capital expenditure | 0 | 49,000 | 0 | 5,000 | 19,000 | 0 |
| Investing cash flow | 0 | −36,000 | 0 | −5,000 | −19,000 | 0 |
| Financing cash flow | 0 | 500,000 | 200,000 | 200,000 | 0 | 851,000 |